Does SECUKINUMAB Cause Neoplasm malignant? 545 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 545 reports of Neoplasm malignant have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.4% of all adverse event reports for SECUKINUMAB.
545
Reports of Neoplasm malignant with SECUKINUMAB
0.4%
of all SECUKINUMAB reports
37
Deaths
82
Hospitalizations
How Dangerous Is Neoplasm malignant From SECUKINUMAB?
Of the 545 reports, 37 (6.8%) resulted in death, 82 (15.0%) required hospitalization, and 22 (4.0%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 545 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which SECUKINUMAB Alternatives Have Lower Neoplasm malignant Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG